tcell-video-fallback.jpg

17th Annual

T-Cell Lymphoma Forum

 January 29-31, 2026

Hyatt Regency La Jolla at Aventine

Conference rate $259
Reservations must be made by December 29, 2025

The 17th Annual T-Cell Lymphoma Forum is the premier global gathering of experts dedicated to advancing the understanding and treatment of T-cell lymphomas. Over two and a half days, the forum will showcase cutting-edge research, emerging therapies, and the latest clinical insights in T-cell lymphoma care.

This year’s agenda features in-depth sessions on molecular pathogenesis, therapeutic innovations, CTCL management, adoptive cellular therapies, and global perspectives on disparities in care. A highlight includes the Fellows Forum, where challenging cases are presented and discussed by leading experts.

Join top scientists, clinicians, and thought leaders in a collaborative environment to tackle pressing challenges and drive progress toward improved patient outcomes.

This activity is not accredited for Continuing Education.

Target audience:

This course has been designed for all clinicians and scientists with an interest in T-cell Lymphoma, including physicians and other healthcare professionals practicing in hematology, oncology, and related fields.

Topics include:

  • Molecular pathogenesis

  • Therapeutic innovations

  • CTCL management

  • Adoptive cellular therapies

  • Global perspectives on disparities in care

For more information:

uvace@uvahealth.org

Call for Abstracts

Abstract Submission Opens Soon!

Co-chaired by:

Francine M. Foss, MD
Yale School of Medicine

Won Seog Kim, MD, PhD
Samsung Medical Center

Owen A. O’Connor, MD, PhD
University of Virginia

Joint Accreditation Provider: